Unternehmens-Profil
Roche Holding AG Genussscheine are bearer participation certificates representing non-voting equity instruments in Roche Holding AG, a Swiss multinational healthcare holding company founded in 1896 and headquartered in Basel, Switzerland. These certificates provide holders with economic exposure to the company's performance without voting rights, distinguishing them from the voting shares controlled largely by the founding families. Roche Holding AG oversees two primary divisions: Pharmaceuticals, focusing on innovative therapies for oncology, neurology, immunology, ophthalmology, haematology, and infectious diseases; and Diagnostics, offering in vitro tests, instruments, and digital solutions for conditions like cancer, diabetes, cardiovascular diseases, and infectious pathogens including COVID-19 and hepatitis. As the fifth-largest pharmaceutical firm globally by revenue and a leader in cancer treatments, Roche drives advancements through substantial R&D investments, strategic acquisitions such as Genentech and Chugai Pharmaceuticals, and a robust pipeline addressing priority health challenges. The Genussscheine play a key role in the financial markets by enabling broad investor participation in Roche's global operations, which span Europe, North America, Asia, and beyond, supporting its mission to deliver transformative healthcare solutions.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 321,9 CHF· Stand 06.05.2026
News · Roche Holding AG
- Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools
- Switzerland's Roche agrees to acquire US-based PathAI
- Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
- Where Roche Fits In A 2026 Portfolio
- Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026